Material & method: From 5/2011 - 5/2012 we used GnRHa for triggering of final oocyte maturation to prevent the development of hyperstimulation syndrome in 15 high-risk patients IVF (GnRH antagonist protocol) and analyzed the incidence of OHSS and clinical outcome in the fresh embryo transfer cycle.